Omkar Speciality Chemicals Limited (OMKARCHEM) AI Stock Analysis

Omkar Speciality Chemicals Limited

(NSE:OMKARCHEM)

Select Model

Rating:42Neutral

Price Target:INR 3.50▼(-2.78% Downside)

Action:initiatedcoverage

Date:09/24/26

The score is driven primarily by very weak financial performance (large losses, severe revenue contraction, and recent cash burn), with only a partial offset from FY2026 balance-sheet improvement. Technicals remain soft with the stock below its 200-day average and negative MACD, while valuation provides limited support due to a negative P/E and no dividend yield data.

Positive Factors

FY2026 Balance-Sheet ImprovementThe return to positive equity and substantially lower reported debt improves financial flexibility compared with the prior period of negative equity. If maintained, this provides a stronger capital base for stabilisation, although the improvement has not yet translated into operating recovery.

Negative Factors

Extreme Revenue ContractionThe collapse in revenue indicates a severe loss of operating scale and materially weakens the company’s ability to absorb fixed costs. Rebuilding a dependable customer and revenue base would be necessary before profitability, cash generation, or competitive position can become durable.

Omkar Speciality Chemicals Limited (OMKARCHEM) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 70.17M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -4.5
Beta (1Y): 0.38
Revenue Growth: ―
EPS Growth: ―
Country: India
Employees: 59
Sector: General
Sector Strength: 55
Industry: Chemicals - Specialty

Omkar Speciality Chemicals Limited Business Overview & Revenue Model

Company Description

Omkar Speciality Chemicals Limited (OSCL) is a prominent manufacturer and global supplier of specialized chemicals and intermediates, catering to a wide array of chemical and allied sectors both domestically in India and across international markets....

Omkar Speciality Chemicals Limited Financial Statement Overview

Summary

Financial quality is very weak: earnings and margins are deeply negative with extreme revenue collapse (from hundreds of millions in FY2021–FY2023 to ~2.2m in FY2025 and ~0.08m in FY2026). The balance sheet shows a notable FY2026 improvement (equity turning positive and lower debt), but it follows multiple years of negative equity and is not yet supported by operating recovery. Cash flow is volatile and recently reverted to negative operating/free cash flow in FY2026, raising near-term funding and execution risk.

Income Statement

8Very Negative

Balance Sheet

18Very Negative

Cash Flow

22Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	82.00K	82.00K	2.24M	229.82M	229.82M	451.25M
Gross Profit	-4.43M	-9.09M	-9.07M	62.82M	62.82M	118.89M
EBITDA	-3.22M	-8.55M	-3.97M	-47.46M	-47.46M	122.75M
Net Income	-6.93M	-15.89M	-13.04M	-126.05M	-126.05M	20.14M
Balance Sheet
Total Assets	0	456.49M	480.38M	721.72M	721.72M	863.63M
Cash, Cash Equivalents and Short-Term Investments	26.48M	26.48M	44.52M	103.46M	3.33M	1.67M
Total Debt	0	31.05M	3.82B	2.26B	2.26B	2.28B
Total Liabilities	-187.25M	269.24M	4.05B	2.43B	2.43B	2.45B
Stockholders Equity	187.25M	187.25M	-3.57B	-1.71B	-1.71B	-1.58B
Cash Flow
Free Cash Flow	0	-16.68M	9.06M	8.92M	8.92M	-164.30M
Operating Cash Flow	0	-14.66M	9.06M	8.92M	8.92M	-164.12M
Investing Cash Flow	0	-2.89M	1.11M	1.75M	1.75M	173.49M
Financing Cash Flow	0	-487.00K	0	-10.36M	-10.36M	-10.80M

Omkar Speciality Chemicals Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price3.60

Price Trends

50DMA3.60Positive

100DMA3.60Negative

200DMA4.05Negative

Market Momentum

MACD-0.00Negative

RSI31.33Neutral

STOCH0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OMKARCHEM, the sentiment is Negative. The current price of 3.60 is above the 20-day moving average (MA) of 3.60, above the 50-day MA of 3.60, and below the 200-day MA of 4.05, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 31.33 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:OMKARCHEM.

Omkar Speciality Chemicals Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:OMKARCHEM against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:FCL	68Neutral	INR 56.58B	40.33	―	0.27%	91.44%	19.67%
IN:ROSSARI	65Neutral	INR 22.12B	14.48	―	0.13%	19.76%	11.74%
IN:CHEMCON	61Neutral	INR 6.73B	22.26	―	3.53%	22.25%	20.33%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:LXCHEM	46Neutral	INR 42.47B	33.72	―	0.20%	5.47%	24.88%
IN:NEOGEN	46Neutral	INR 65.47B	163.88	―	0.05%	18.00%	3.85%
IN:OMKARCHEM	42Neutral	INR 74.08M	-4.55	―	―	―	―

* General Sector Average

Performance Comparison

IN:OMKARCHEM and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:OMKARCHEM	Omkar Speciality Chemicals Limited	3.60	-2.05	-36.28%
IN:CHEMCON	Chemcon Speciality Chemicals Ltd	183.85	-52.58	-22.24%
IN:FCL	Fineotex Chemical Limited	48.59	16.55	51.67%
IN:LXCHEM	Laxmi Organic Industries Ltd.	152.80	-43.86	-22.30%
IN:NEOGEN	Neogen Chemicals Ltd.	2179.35	717.56	49.09%
IN:ROSSARI	Rossari Biotech Ltd	399.25	-242.58	-37.79%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 24, 2026

Omkar Speciality Chemicals Limited AI Stock Analysis